Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on November 5, 2026

Nov. 5, 2026

Sparrow Pharmaceuticals Announces Expansion Cohorts in Phase 2b CAPTAIN-T2D Trial to Evaluate Clofutriben Across the Full Range of Cortisol Levels in Difficult-to-Control Type 2 Diabetes

Indeterminate GlobeNewswire

Nov. 5, 2026

Dogwood Therapeutics Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Disc Medicine Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion

Indeterminate GlobeNewswire

Nov. 5, 2026

Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Nuwellis Submits FDA 510(k) to Expand Aquadex SmartFlow® Indication to Include Pediatric Patients Weighing 5 kg and Above

Indeterminate GlobeNewswire

Nov. 5, 2026

Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics

Indeterminate GlobeNewswire

Nov. 5, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Annovis Announces Pricing of $21.0 Million Public Offering

Indeterminate GlobeNewswire

Nov. 5, 2026

Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 5, 2026

LightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)

Indeterminate GlobeNewswire

Nov. 5, 2026

Taysha Gene Therapies to Release Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 12

Indeterminate GlobeNewswire

Nov. 5, 2026

SpyGlass Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Novastra Therapeutics Establishes Scientific Advisory Board and Appoints Senior Advisors and Head of Clinical Development

Indeterminate GlobeNewswire

Nov. 5, 2026

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 5, 2026

Forward Therapeutics Announces U.S. FDA IND Clearance to Initiate Phase 2 Study of FT2109 in Psoriatic Arthritis

Indeterminate GlobeNewswire